Mark A. Goldsmith
- Virology top 0.2%
- HIV Research and Treatment 27
- Immunology top 0.5%
- Immune Cell Function and Interaction 46
- T-cell and B-cell Immunology 28
- Immune Response and Inflammation 10
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 7
- Oncology top 2%
- Cytokine Signaling Pathways and Interactions 22
- Gastroenterology top 2%
-
- Monoclonal and Polyclonal Antibodies Research 9
-
- Antiplatelet Therapy and Cardiovascular Diseases 5
- Co-authors
- Arthur WeissKathleen D. LiuRobert E. AtchisonWarner C. GreeneRoberto F. SpeckSarah L. GaffenC. MelissaIsrael Charo
- Journals
- Journal of Virology (16 papers)Journal of Biological Chemistry (11 papers)Proceedings of the National Academy of Sciences (8 papers)
- Partner nations
- United StatesSlovakiaCanada
In The Last Decade
Mark A. Goldsmith
91 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Virology 1.9k
- Immunology 2.9k
- Infectious Diseases 1.2k
- Oncology 1.5k
- Gastroenterology 293
Countries citing papers authored by Mark A. Goldsmith
This map shows the geographic impact of Mark A. Goldsmith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Goldsmith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Goldsmith more than expected).
Fields of papers citing papers by Mark A. Goldsmith
This network shows the impact of papers produced by Mark A. Goldsmith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Goldsmith. The network helps show where Mark A. Goldsmith may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark A. Goldsmith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 8 | |
| 4 | 2020 | 69 | |
| 5 | 2016 | 1 | |
| 6 | 2016 | 33 | |
| 7 | Clopidogrel with or without Omeprazole in Coronary Artery Diseasebreakdown → | 2010 | 794 |
| 8 | 2009 | 16 | |
| 9 | 2005 | 38 | |
| 10 | 2005 | 32 | |
| 11 | 2003 | 9 | |
| 12 | 2003 | 105 | |
| 13 | 2001 | 16 | |
| 14 | 2001 | 171 | |
| 15 | 2000 | 13 | |
| 16 | 1999 | 47 | |
| 17 | 1997 | 87 | |
| 18 | 1995 | 66 | |
| 19 | 1988 | 119 | |
| 20 | 1988 | 7 |
About Mark A. Goldsmith
Mark A. Goldsmith is a scholar working on Virology, Immunology, Oncology, Infectious Diseases and Gastroenterology, having authored 91 papers that have together received 6.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (46 papers), T-cell and B-cell Immunology (28 papers), HIV Research and Treatment (27 papers), Cytokine Signaling Pathways and Interactions (22 papers), Immune Response and Inflammation (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), HIV/AIDS drug development and treatment (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). The work is most often cited by research in Virology (1.9k citations), Immunology (2.9k citations), Infectious Diseases (1.2k citations), Oncology (1.5k citations) and Gastroenterology (293 citations). Mark A. Goldsmith has collaborated with scholars based in United States, Slovakia and Canada. Frequent co-authors include Arthur Weiss, Kathleen D. Liu, Robert E. Atchison, Warner C. Greene, Roberto F. Speck, Sarah L. Gaffen, C. Melissa, Israel Charo, Yun You and Stephen Y. Lai. Their work appears in journals such as Journal of Virology, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Blood and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.